Source: Hepatology. Unidade: FM
Subjects: HOSPEDEIRO IMUNOCOMPROMETIDO, INFECÇÕES POR HIV, FARMACODINÂMICA, RESUMOS (EVENTOS), HEPATITE C (VIROLOGIA), HEPATITE VIRAL HUMANA
ABNT
ARAÚJO, Evaldo S. et al. Pharmacodynamics of peg-ifn alpha-2a and hcv response as a function of il28b polymorphism in hiv/hcv co-infected patients. Hepatology. Baltimore: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 05 maio 2026. , 2010APA
Araújo, E. S., Dahari, H., Cotler, S. J., Layden, T. J., Neumann, A. U., Melo, C. E., & Barone, A. A. (2010). Pharmacodynamics of peg-ifn alpha-2a and hcv response as a function of il28b polymorphism in hiv/hcv co-infected patients. Hepatology. Baltimore: Faculdade de Medicina, Universidade de São Paulo.NLM
Araújo ES, Dahari H, Cotler SJ, Layden TJ, Neumann AU, Melo CE, Barone AA. Pharmacodynamics of peg-ifn alpha-2a and hcv response as a function of il28b polymorphism in hiv/hcv co-infected patients. Hepatology. 2010 ; 52( 4 (suppl): 750A.[citado 2026 maio 05 ]Vancouver
Araújo ES, Dahari H, Cotler SJ, Layden TJ, Neumann AU, Melo CE, Barone AA. Pharmacodynamics of peg-ifn alpha-2a and hcv response as a function of il28b polymorphism in hiv/hcv co-infected patients. Hepatology. 2010 ; 52( 4 (suppl): 750A.[citado 2026 maio 05 ]